FGC
HAE icon

Financial Gravity Companies’s Haemonetics HAE Stock Holding History

Financial Gravity Companies’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$41K Buy
+424
New +$44.5K 0.04% 388
2018
Q1 		$1K Sell
11
-565
-98% -$38.8K ﹤0.01% 1146
2017
Q4 		$37K Buy
+576
New +$30.3K 0.04% 365

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Financial Gravity Companies's HAE Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Haemonetics (HAE) in Q4 2018: 424 shares worth $41K. The stake represents 0.04% of the portfolio and ranks #388 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in HAE as recently as Q1 2018.

Financial Gravity Companies first reported a position in HAE in Q4 2017 and has held it in 3 quarters since. 279 funds tracked by Wall St. Rank hold HAE as of Q4 2018.

  • Financial Gravity Companies held 424 shares of Haemonetics worth $41K as of Q4 2018.
  • Haemonetics was a new Financial Gravity Companies position in Q4 2018.
  • Haemonetics made up 0.04% of Financial Gravity Companies's portfolio in Q4 2018, its #388 holding.
  • Financial Gravity Companies first reported a position in Haemonetics in Q4 2017 and has held it in 3 quarters since.
  • 279 funds tracked by Wall St. Rank held Haemonetics as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.